This course is no longer available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase.
It would need to be repurchased by the trainee if not completed in the allotted time period.
This course is no longer available.
You will need to repurchase if you wish to take the course again.

Description

Clinical trials provide an opportunity for pet owners to seek advanced veterinary care when standard therapies are either ineffective or inaccessible. The cost of care is often subsidized and both pets and their owners are well supported. Owners will enroll their pets in clinical trials for several reasons including the desire to offer treatment when other options are not affordable or possible, the desire to contribute to the greater good, and the desire to provide a novel and promising therapy to their pet. Connecting the appropriate trial patient with a trial suited to that cancer and presentation can be challenging. This talk will review clinical trial design, important aspects of trials, responsibilities of the owner and veterinary care team, a sampling of current trials across the country, and ways to find these trials through a central, searchable, online database.

Objectives

Learning Objectives:

• Understand the different phases of clinical trials for anticancer therapy development
• Understand how trial design can affect interpretation of results
• Be familiar with web-based resources to find clinical trials for animals with cancer, and how to participate in trials and their promotion.

Dr. Kim Selting - Dr. Selting grew up in Colorado, where she completed undergraduate, veterinary, and specialty training at Colorado State University. A rotating internship was completed at the Animal Medical Center in New York City after earning her DVM. Upon completion of her medical oncology residency and achieving board certification, she joined the faculty at the University of Missouri in 2002. In 2013, she also completed a non-conforming residency in radiation oncology and achieved board certification. Professional interests include biomarkers in blood and breath, novel chemotherapy drugs (such as satraplatin), and targeted radioisotope therapy.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s: